TARA Protara Therapeutics Inc
Company Analysis
Latest News
🟢 Protara Therapeutics is trading 5.5% up today as risk appetite rebounds and small-cap biotechs recover
Protara Therapeutics is trading 5.5% up at $4.02 as it bounces from recent weakness and benefits from a broader risk-on move in U.S. equities. • The move...
🟢 Protara Therapeutics is trading 12.9% up today as it rebounds from recent weakness
Protara Therapeutics is trading at $4.30 (12.9%) up in pre-market, reversing several days of declines as broader market sentiment improves. • The jump appears...
🟢 Protara Therapeutics is trading 5.7% up today amid a broader risk-on market rally
Protara Therapeutics is trading 5.7% up today at $4.25 in pre-market, rebounding from a flat-to-slightly-negative week as U.S. equities experience a broader...
🔴 TARA is trading 5.3% down today amid a broader risk-off tone in equities
TARA is trading 5.3% down at $4.04 following a sharp pullback that appears driven by broader market sentiment rather than company-specific developments. • No...
🔴 TARA is trading 6.1% down today with no clear company-specific catalyst found
TARA is trading at $4.01 (-6.09%) in pre-market following a sharp overnight pullback despite a lack of company-specific news. • No earnings reports, FDA...
🟢 TARA makes sharp 10.0% jump
TARA is trading at $4.49, up 10.0% versus the comparison close of $4.08 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 TARA is trading 5.5% up today as it holds above $4.00 amid biotech sector momentum
TARA is trading at $4.30 (+5.51%) as the stock holds above key support levels amid broader biotech sector momentum. • The move follows a strong pre-market...
🟢 Protara Therapeutics Inc is trading 6.62% up in pre-market
TARA is trading at $4.35, up 6.62% in pre-market.
🟢 TARA is trading 5.1% up today following a JPMorgan price-target note and a rebound from the June 30 selloff
TARA is trading at $4.01 (+5.10%) as buyers step in following a JPMorgan price-target note and a technical rebound from the June 30 selloff. • The move...
Protara's Top Doctor Lasted Just 14 Months — Can a Tiny Biotech Keep Its Clinical Momentum Without a CMO?
Shares of Protara Therapeutics slid 7.7% to $3.84 on Monday as investors reacted to the sudden departure of Chief Medical Officer Leonardo Nicacio, who...
🔴 TARA is trading 7.7% down today following CMO resignation
TARA is trading 7.7% down at $3.84 following the announced resignation of its Chief Medical Officer, effective June 26, 2026. • The leadership change...
Protara Therapeutics Announces Resignation of Chief Medical Officer
Protara Therapeutics, Inc. (TARA) announced the resignation of its Chief Medical Officer, Leonardo Viana Nicacio, M.D., effective June 26, 2026. The company...
🔴 TARA is trading 3.8% down today as momentum cools after recent low-float spike
TARA is trading at $3.85 (3.8% down) in pre-market, easing back after recent low-float biotech-driven volatility. • The stock is experiencing a normal...
🔴 TARA is trading 3.8% down today on low-float biotech volatility and repositioning
TARA is trading 3.8% down at $3.85 in pre-market on low-float biotech volatility and repositioning. • The move gives back part of a recent surge that followed...
🟢 TARA is trading 8.5% up today on low-float biotech volatility
TARA is trading at $4.46 (8.51% up) as the move appears driven by low-float biotech volatility and market positioning rather than a specific company...
🟢 Protara Therapeutics Inc is trading 5.1% up today after shareholders approve doubling authorized common stock
Protara Therapeutics Inc is trading 5.1% up at $4.00 after investors reacted to shareholder approval to increase the company's authorized common stock from 100...
Protara Doubles Its Share Ceiling — Is Management Quietly Loading the Gun for a Big Capital Raise?
Shares of Protara Therapeutics jumped 7.9% to $4.25 in pre-market trading after shareholders at the company's June 12 annual meeting voted overwhelmingly to...
🟢 Protara Therapeutics Inc is trading 7.9% up today after shareholders approved doubling authorized common stock
Protara Therapeutics Inc is trading 7.9% up at $4.25 in pre-market trading after investors reacted to news from the company's 2026 Annual Meeting. •...
Protara Therapeutics Shareholders Approve Doubling Authorized Common Stock to 200M
Protara Therapeutics announced the results of its 2026 Annual Meeting of Stockholders, where shareholders approved several key proposals, most notably an...
Protara Therapeutics Shares Fall Despite Positive Analyst Ratings
Protara Therapeutics (TARA) shares declined nearly 15% in after-hours trading on Friday, June 12, 2026. The stock had closed the regular session with a 9%...